Natural Bacteriocins as Potential Drug Candidates Targeting Core Proteins in Mastitis Pathogens of Dairy Cattle

Soharth Hasnat,Md. Morshedur Rahman,Farzana Yeasmin,Mohammad Jubair,Yosra A. Helmy,Tofazzal Islam,M. Nazmul Hoque
DOI: https://doi.org/10.1101/2024.11.05.622021
2024-11-08
Abstract:Mastitis poses a major challenge in the dairy industry, with rising antibiotic-resistant strains underscoring the urgent need for alternative antimicrobial strategies. This study aimed to (i) identify essential core proteins in clinical mastitis (CM)-causing pathogens using genomic approach, and (ii) assess the efficacy of natural antimicrobial peptides as novel therapeutic agents targeting the selected core proteins for the rational management of mastitis in dairy cows. Through a core genomic analysis of 16 CM-causing pathogens, including strains of Staphylococcus aureus, S. warneri, Streptococcus agalactiae, S. uberis, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, P. putida, and P. asiatica, we identified 65 core proteins shared among these pathogens. Among them, ten proteins including PhoH, TrpB, FtsZ, HslV, HupB, RibH, InfA, MurA, GlxK, and Rho were found to be essential for the survival and virulence of these pathogens. Importantly, further novelty, resistance, and virulence assessments identified Rho and HupB as potential therapeutic targets. A comprehensive screening of 70 bacteriocin peptides (BPs) revealed 14 BPs that effectively interacted with both Rho and HupB proteins. Further analysis showed that BP8 and BP32 disrupt Rho protein function by blocking transcription termination process, while BP8, BP39, and BP40 prevent HupB from binding to DNA. These findings confirm the promising stability and efficacy of BP8 against both target proteins in CM-pathogens, highlighting it as a promising broad-spectrum therapeutic agent. Our computational study identified Rho and HupB as key proteins in CM-causing pathogens, which can be targeted by natural bacteriocins like BP8, suggesting its potential for developing effective and sustainable therapeutics against mastitis in dairy cattle.
Bioinformatics
What problem does this paper attempt to address?
### Problems the paper attempts to solve This paper aims to address the challenges faced in the treatment of bovine mastitis, especially the increase in antibiotic - resistant strains, which highlights the urgency of finding alternative antibacterial strategies. Specifically, the objectives of the paper are: 1. **Identify core proteins**: Through genomics methods, identify the core proteins in the pathogens causing clinical mastitis (CM). 2. **Evaluate the effects of natural antimicrobial peptides**: Evaluate the effectiveness of natural antimicrobial peptides (especially bacteriocins) as novel therapeutic agents, which can target the identified core proteins for the rational management of bovine mastitis. ### Specific research contents - **Genome analysis**: Through core genome analysis of 16 pathogens causing clinical mastitis, 65 core proteins shared among these pathogens were identified. - **Screening of key proteins**: Among these core proteins, proteins that are crucial for the survival and virulence of the pathogens, such as PhoH, TrpB, FtsZ, HslV, HupB, RibH, InfA, MurA, GlxK and Rho, were further screened out. - **Screening of antimicrobial peptides**: From 70 bacteriocin peptides (BPs), 14 BPs that can effectively interact with Rho and HupB proteins were screened out. - **Functional verification**: Further analysis showed that BP8 and BP32 disrupt the function of the Rho protein by blocking the transcription termination process, while BP8, BP39 and BP40 prevent HupB from binding to DNA. - **Stability analysis**: The stability of the complexes formed by Rho and HupB with BP8 was evaluated by molecular dynamics simulation (MDS), and the results showed that BP8 has good stability and effectiveness against the target proteins. ### Conclusions This study identified Rho and HupB as key therapeutic targets for mastitis pathogens and found that BP8 is a potential broad - spectrum therapeutic agent that can effectively target these targets. This finding provides new ideas for the development of effective and sustainable mastitis treatment methods.